| [1] |
中国研究型医院学会皮肤科学专业委员会, 中国医师协会皮肤科医师分会. 白癜风光疗指南(2025版)[J]. 中华皮肤科杂志, 2025,58(3):197⁃208. DOI: 10.35541/cjd.20240547.
|
| [2] |
Bae JM, Jung HM, Hong BY, et al. Phototherapy for vitiligo: a systematic review and meta⁃analysis[J]. JAMA Dermatol, 2017,153(7):666⁃674. DOI: 10.1001/jamadermatol.2017.0002.
|
| [3] |
中国研究型医院学会. T/CRHA 255—2025白癜风患者家庭光疗管理规范[S/OL]. (2025⁃12⁃22)[2025⁃12⁃31]. https://www.ttbz.org.cn/standardDetail/gaw815t24t7v44lmprdwslil7lb338b.html.
|
| [4] |
国家市场监督管理总局, 中国国家标准化管理委员会. GB/T 1.1⁃2020标准化工作导则 第1部分:标准化文件的结构和起草规则[S/OL]. (2020⁃03⁃31)[2025⁃12⁃31]. https://openstd.samr.gov.cn/bzgk/std/newGbInfo?hcno=C4BFD981E993C417EF475F2A19B681F1.
|
| [5] |
天津市医疗器械质量监督检验中心. YY/T 0901⁃2013紫外治疗设备[S/OL]. (2013⁃10⁃21)[2025⁃12⁃31]. https://app.nifde.org.cn/biaogzx/dataGkZqyjdo? formAction=viewZqyi&id=2c9048d 88abc4329018acae8ee8b3edf.
|
| [6] |
中国研究型医院学会. T/CRHA 147—2025皮肤病家庭紫外线光疗规范[S/OL]. (2025⁃03⁃10)[2025⁃12⁃31]. https://www.ttbz.org.cn/standardDetail/jcdztg4zpohnqsd0zskr3q0pdetxi14.html.
|
| [7] |
上海市生物医学工程学会. T/SSBME 2—2025家用LED紫外治疗设备[S/OL]. (2025⁃06⁃27)[2025⁃12⁃31]. https://www.ttbz.org.cn/standardDetail/0y7mf5jabpnf8zndym1ck0el98j9t9y.html.
|
| [8] |
中国中西医结合学会皮肤性病专业委员会色素病学组, 中华医学会皮肤性病学分会白癜风研究中心, 中国医师协会皮肤科医师分会色素病专委会. 白癜风诊疗共识(2024版)[J]. 中华皮肤科杂志, 2024,57(12):1065⁃1070. DOI: 10.35541/cjd. 20240260.
|
| [9] |
Gupta V, Sreenivas V, Mehta M, et al. What do vitiligo impact scale⁃22 scores mean? Studying the clinical interpretation of scores using an anchor⁃based approach[J]. Br J Dermatol, 2019,180(3):580⁃585. DOI: 10.1111/bjd.16708.
|
| [10] |
Verhaeghe E, Lodewick E, van Geel N, et al. Intrapatient comparison of 308⁃nm monochromatic excimer light and localized narrow⁃band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial[J]. Dermatology, 2011,223(4):343⁃348. DOI: 10.1159/000330567.
|
| [11] |
Poolsuwan P, Churee C, Pattamadilok B. Comparative efficacy between localized 308⁃nm excimer light and targeted 311⁃nm narrowband ultraviolet B phototherapy in vitiligo: a randomized, single⁃blind comparison study[J]. Photodermatol Photoimmunol Photomed, 2021,37(2):123⁃130. DOI: 10.1111/phpp.12642.
|
| [12] |
Mohammad TF, Al⁃Jamal M, Hamzavi IH, et al. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo[J]. J Am Acad Dermatol, 2017,76(5):879⁃888. DOI: 10.1016/j.jaad.2017.01.048.
|
| [13] |
Menteşoğlu D, Kurmuş GI, Kartal SP. Use of narrow⁃band ultraviolet B in pediatric dermatology patients: ten years of experience from a tertiary care hospital[J]. Arch Dermatol Res, 2025,317:626. DOI: 10.1007/s00403⁃025⁃05826⁃3.
|
| [14] |
Goulden V, Ling TC, Babakinejad P, et al. British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022[J]. Br J Dermatol, 2022,187(3):295⁃308. DOI: 10.1111/bjd.21126.
|
| [15] |
Lee J, Chu H, Lee H, et al. A retrospective study of methylprednisolone mini⁃pulse therapy combined with narrow⁃band UVB in non⁃segmental vitiligo[J]. Dermatology, 2016,232(2):224⁃229. DOI: 10.1159/000445020.
|
| [16] |
Xu Z, Xuan Y, Li Y, et al. A prospective observational study of oral abrocitinib and narrow⁃band ultraviolet⁃B in refractory progressive vitiligo[J]. J Am Acad Dermatol, 2024,91(3):590⁃592. DOI: 10.1016/j.jaad.2024.04.036.
|
| [17] |
Zhang W, Zhai S, Dou J, et al. Short⁃term efficacy and safety of upadacitinib combined with 308 excimer light versus upadacitinib alone and 308 excimer light alone in patients with progressing facial vitiligo[J]. Arch Dermatol Res, 2025,317:252. DOI: 10.1007/s00403⁃025⁃05592⁃6.
|
| [18] |
Seneschal J, Speeckaert R, Taïeb A, et al. Worldwide expert recommendations for the diagnosis and management of vitiligo: position statement from the international Vitiligo Task Force⁃Part 2: specific treatment recommendations[J]. J Eur Acad Dermatol Venereol, 2023,37(11):2185⁃2195. DOI: 10.1111/jdv.19308.
|
| [19] |
Zubair R, Hamzavi IH. Phototherapy for vitiligo[J]. Dermatol Clin, 2020,38(1):55⁃62. DOI: 10.1016/j.det.2019.08.006.
|
| [20] |
Bae JM, Ju HJ, Lee RW, et al. Evaluation for skin cancer and precancer in patients with vitiligo treated with long⁃term narrowband UV⁃B phototherapy[J]. JAMA Dermatol, 2020,156(5):529⁃537. DOI: 10.1001/jamadermatol.2020.0117.
|